Comparison of immunomodulative effects of histamine-2 receptor antagonists in gastric cancer patients: Focus on the lymphoblastogenesis and cytotoxicity of peripheral blood mononuclear cells

This publication has 33 references indexed in Scilit:

• In vitro augmentation of the cytotoxic activity of peripheral blood mononuclear cells and tumor-infiltrating lymphocytes by famotidine in cancer patients
  International Journal of Immunopharmacology, 1992
• EFFECT OF CIMETIDINE ON SURVIVAL AFTER GASTRIC CANCER
  The Lancet, 1988
• Clinical improvement in advanced cancer disease after treatment combining histamine and H2-antihistaminics (ranitidine or cimetidine)
  European Journal of Cancer and Clinical Oncology, 1988
• Augmented natural killer activity in ovarian cancer patients treated with cimetidine
  European Journal of Cancer and Clinical Oncology, 1986
• Role of histamine in tumor development
  Trends in Pharmacological Sciences, 1985
• Immunoregulatory T cells in man. Histamine-induced suppressor T cells are derived from a Leu 2+ (T8+) subpopulation distinct from that which gives rise to cytotoxic T cells.
  Journal of Clinical Investigation, 1985
• Characteristics of histamine receptors present on suppressor T cells in “healthy individuals”
  International Journal of Immunopharmacology, 1985
• CIMETIDINE AND THE IMMUNE RESPONSE
  The Lancet, 1979
• ANTITUMOUR EFFECT OF CIMETIDINE?
  The Lancet, 1979
• Histamine suppression of human lymphocyte responses to mitogens
  Cellular Immunology, 1978